Arctic Bioscience – Capital markets update
Today, Arctic Bioscience, a biotech company developing, and commercializing nutraceutical and pharmaceutical products based on the unique properties of bioactive marine compounds, host a Capital Markets Update in Oslo.“During challenging times Arctic Bioscience has worked hard to stay on track with the development plan for HRO350, and we are now in a position to take the next steps in this development plan. We look forward to meeting with investors and other capital market stakeholders to give an update on the company and hopefully provide meaningful discussions”, says Christer L.